Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to
- Posted February 21, 2022
- 8:14 am

US 10406105B2Pharmaceutical formulation for the production of rapidly disintegrating tabletsBASF SE (Ludwigshafen, DE)Karl K,Michael S,Silke G,Kathrin MB,Angelika M.10-09-2019Kollidon CL-SFSuper disintegrantKollidon 30BinderKollidon VA 64BinderKollicoat SR 30 DDispersing agentEP 2001450B1Directly compressible composite for orally disintegrating tabletsRubicon Research Private Limited (Mumbai, IN)Pilgaonkar PS,Rustomjee MT,Gandhi AS,Bagde P,Morvekar HN.30-01-2019CrospovidoneDisintegrantUS 20180036245A1Solid dispersionsShionogi Inc. (Florham Park, NJ, US)Zhengming C,Xiaoming C,Kevin H.08-02-2018Kollidon 30…
view related posts